Article Text

Download PDFPDF

115 Cardiovascular effects of living kidney donation: a five year longitudinal study
  1. Anna Price1,
  2. William Moody2,
  3. Victoria Stoll2,
  4. Ravi Vijapurapu2,
  5. Manvir Hayer2,
  6. Luca Biasiolli3,
  7. Chris Weston4,
  8. Rachel Webster2,
  9. Roman Wesolowski2,
  10. Kirsty McGee4,
  11. Nicola Edwards5,
  12. Boyang Liu2,
  13. Shanat Baig2,
  14. Luke Pickup2,
  15. Ashwin Radhakrishnan2,
  16. Jonathan Law2,
  17. Rick Steeds6,
  18. Charles Ferro2,
  19. Jonathan Townend2
  1. 1University Hospitals Birmingham
  2. 2Queen Elizabeth Hospital Birmingham
  3. 3University of Oxford
  4. 4University of Birmingham
  5. 5Green Lane Cardiovascular Service
  6. 6University Hospitals Birmingham NHS Foundation Trust


Background The inverse association between estimated glomerular filtration rate (eGFR) and cardiovascular risk is well recognised but not fully explained. Kidney donation is known to reduce renal function by approximately 30% and allows the prospective study of the cardiovascular effects of a reduced eGFR in healthy subjects without confounding comorbidities. We report five year results in a group of kidney donors and healthy controls who underwent extensive cardiovascular assessment.

Methods A 5 year longitudinal, parallel group, blinded end-point study of living kidney donors (n=50) and healthy controls (n=45). Participants underwent office and 24-hr ambulatory blood pressure measures, multi-parametric cardiac magnetic resonance imaging (MRI) (3 Tesla), measurement of arterial stiffness (SphygmoCor), carotid intima-media thickness and blood and urine analysis at baseline, one year and 5 years from donation.

Results The eGFR in donors at baseline was 95 ± 15ml/min/1.73m2, 65 ± 13ml/min/1.73m2 at one year and 67 ± 14ml/min/1.73m2 at 5 years. Left ventricular (LV) mass was 112g at baseline in both groups and was not different at 5 years (113 ± 31 vs. 115 ± 30, p=0.707). There was also no difference in LV volumes, LV geometry, LV function, T1 times or extracellular volume (ECV) on MRI. Office and ambulatory blood pressures did not differ from controls at any time point. Pulse wave velocity was higher in donors at one year but not significantly different by 5 years. At 5 years, there was no significant differences in the prevalence of a detectable troponin or mean plasma NT pro-BNP.

Conclusion The stable reduction in eGFR to levels of 60-70 ml/min/1.73m2 after live kidney donation does not lead to deleterious changes in cardiovascular structure and function or biomarkers of cardiovascular disease at 5 years. Factors associated with kidney disease other than an isolated fall in eGFR are likely to explain the increased cardiovascular risk in patients with chronic kidney disease.

Figure A and B: Longitudinal change in LV mass and PWV before and after donation in donors and controls. Black solid lines are means with confidence intervals for donors and dashed lines represent controls. Black squares indicate study visits. A; Left ventricular mass (g) and B; Adjusted pulse wave velocity (m/s) (adjusted for mean arterial pressure and heart rate).

Conflict of Interest None

  • Living Kidney Donors
  • Arterial stiffness
  • Left ventricular mass

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.